Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2020

Conditions
Heart Defects, Congenital
Interventions
DEVICE

Vascular Graft, Model COR-VG-001

The intended use of the Xeltis Vascular Graft, Model COR-VG-001 is to create an extracardiac total cavopulmonary connection (EC-TCPC) connection to divert the venous blood from the inferior vena cava to the pulmonary arteries without passing through the morphologic right ventricle reducing the volume load on the functional single ventricle and thereby improving hemodynamics by minimizing the deleterious effects of ventricular hypertrophy.

Trial Locations (1)

121552

Bakoulev Center of Cardiovascular Surgery, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Technomics Research

INDUSTRY

lead

Xeltis

INDUSTRY